- Home
- MNPR vs HIVE Comparison
MNPR vs HIVE Comparison
Compare MNPR & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- HIVE
- Stock Information
- Founded
- MNPR 2014
- HIVE 1987
- Country
- MNPR United States
- HIVE Canada
- Employees
- MNPR N/A
- HIVE N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- HIVE
- Sector
- MNPR Health Care
- HIVE
- Exchange
- MNPR Nasdaq
- HIVE Nasdaq
- Market Cap
- MNPR 244.1M
- HIVE 276.6M
- IPO Year
- MNPR 2019
- HIVE N/A
- Fundamental
- Price
- MNPR $40.33
- HIVE $1.50
- Analyst Decision
- MNPR Strong Buy
- HIVE Strong Buy
- Analyst Count
- MNPR 5
- HIVE 7
- Target Price
- MNPR $49.60
- HIVE $7.64
- AVG Volume (30 Days)
- MNPR 30.6K
- HIVE 8.7M
- Earning Date
- MNPR 05-08-2025
- HIVE 02-11-2025
- Dividend Yield
- MNPR N/A
- HIVE N/A
- EPS Growth
- MNPR N/A
- HIVE N/A
- EPS
- MNPR N/A
- HIVE N/A
- Revenue
- MNPR N/A
- HIVE $120,999,000.00
- Revenue This Year
- MNPR $34.06
- HIVE $2.40
- Revenue Next Year
- MNPR N/A
- HIVE $179.59
- P/E Ratio
- MNPR N/A
- HIVE N/A
- Revenue Growth
- MNPR N/A
- HIVE 26.29
- 52 Week Low
- MNPR $1.72
- HIVE $1.48
- 52 Week High
- MNPR $54.30
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- MNPR 56.65
- HIVE 28.71
- Support Level
- MNPR $36.80
- HIVE $1.62
- Resistance Level
- MNPR $43.00
- HIVE $1.83
- Average True Range (ATR)
- MNPR 5.32
- HIVE 0.10
- MACD
- MNPR 0.94
- HIVE 0.02
- Stochastic Oscillator
- MNPR 63.41
- HIVE 5.71
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.